Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach
Crossref DOI link: https://doi.org/10.1007/s13205-018-1239-6
Published Online: 2018-04-27
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Anbarasu, K.
Jayanthi, S.
Text and Data Mining valid from 2018-04-27
Article History
Received: 23 June 2017
Accepted: 2 April 2018
First Online: 27 April 2018
Compliance with ethical standards
:
: The authors declare no conflict of interest.